EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--March 30, 2006--Esprit Pharma, Inc., a specialty pharmaceutical company today announced that it has secured a $50 million credit facility from Drawbridge Special Opportunities Fund, a fund managed by an affiliate of Fortress Investment Group, a prominent global investment firm headquartered in New York City. Esprit’s focus is on the acquisition, development and marketing of products for the Genito-urinary and women’s health care markets.
